Professional Medical Expertise Management
Management criteria checks 1/4
Professional Medical Expertise's CEO is Amr Mahmoud Elamayem, appointed in Mar 2011, has a tenure of 13.83 years. directly owns 2.12% of the company’s shares, worth SAR6.74M. The average tenure of the management team and the board of directors is 3 years and 2.4 years respectively.
Key information
Amr Mahmoud Elamayem
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.8yrs |
| CEO ownership | 2.1% |
| Management average tenure | 3yrs |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
CEO
Amr Mahmoud Elamayem (43 yo)
13.8yrs
Tenure
Dr. Amr Mahmoud Abu Elamayem is Executive Vice Chairman of Professional Medical Expertise Company from August 04, 2022 and serves as its Managing Director since March 14, 2011. Dr. Elamayem holds Master’s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & MD | 13.8yrs | no data | 2.12% SAR 6.7m | |
| Finance Manager | 2.8yrs | no data | no data | |
| Operations Manager | 3yrs | no data | no data | |
| Human Resources Manager | 3yrs | no data | no data | |
| Director of Regulatory Affairs | 2.4yrs | no data | no data |
3.0yrs
Average Tenure
43yo
Average Age
Experienced Management: 9574's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & MD | 2.4yrs | no data | 2.12% SAR 6.7m | |
| Director of Regulatory Affairs | 2.1yrs | no data | no data | |
| Independent Director | 2.4yrs | no data | no data | |
| Independent Director | 2.4yrs | no data | no data | |
| Independent Chairman | 2.4yrs | no data | no data | |
| Non-Executive Director | 3.1yrs | no data | no data |
2.4yrs
Average Tenure
51yo
Average Age
Experienced Board: 9574's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 14:05 |
| End of Day Share Price | 2025/01/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Professional Medical Expertise Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|